A physical therapist reviews the medical chart of a patient who has been taking prednisone daily for 20 months to manage an autoimmune condition. The patient presents with central adiposity, hypertension, proximal muscle weakness, and purple abdominal striae. Which of the following BEST describes the physiologic mechanism responsible for this clinical presentation?

Option 1- Excess aldosterone secretion
Option 2- Excess growth hormone secretion
Option 3- Chronic insulin resistance
Option 4- Sustained cortisol elevation

Transcript

Welcome back to the Scorebuilders' Question and Answer Podcast! This podcast provides members of the Scorebuilders' team with the opportunity to explore challenging multiple-choice examination questions with students actively preparing for the licensing examination.

Ready? Let's go!

The clinical presentation for this patient is consistent with Cushing's syndrome. Prolonged use of glucocorticoids, such as prednisone, can result in Cushing's syndrome, producing a characteristic pattern of metabolic, musculoskeletal, and integumentary system changes.

Before we look at the options, let's establish the clinical reasoning framework this question demands. The question is not simply asking you to name a condition - it is asking you to identify the physiologic mechanism responsible for a specific cluster of findings. Four different hormonal or metabolic mechanisms are offered, and your task is to trace the clinical findings in the question stem back to their root cause. The patient has been on prednisone - a synthetic glucocorticoid - for 20 months. Long-term glucocorticoid use has well-documented systemic effects, and the findings described - central adiposity, hypertension, proximal muscle weakness, and purple abdominal striae - form a recognizable clinical pattern. The question is testing whether you can connect those findings to the correct underlying mechanism rather than to a superficially similar hormonal disorder. Keep the specific findings in the stem in front of you as we evaluate each option.

Let's explore each of the options:

Option 1- Excess aldosterone secretion

Excess aldosterone secretion describes hyperaldosteronism, also known as Conn syndrome, which causes hypertension and hypokalemia through renal sodium and water retention. It does not account for the proximal muscle weakness, purple striae, or central adiposity seen in this patient.

Aldosterone is a mineralocorticoid - its primary role is regulating sodium and water balance in the kidneys. Excess aldosterone does produce hypertension through sodium and water retention, which is one finding this patient shares. However, hypertension alone is not enough to select this option - the question asks for the mechanism that explains the entire clinical picture. In this case, three of the four clinical findings in this patient are unexplained by aldosterone excess, which makes this option an incomplete and therefore incorrect answer.

Option 2- Excess growth hormone secretion

Excess growth hormone secretion causes acromegaly in adults, characterized by abnormal enlargement of the hands, feet, facial bones, and internal organs. It does not produce the clinical features of corticosteroid-induced Cushing's syndrome.

The clinical picture here - central adiposity, proximal weakness, striae, and hypertension - has no mechanistic connection to growth hormone excess. This option can be eliminated quickly by recognizing that the findings described belong to a completely different hormonal disorder with a completely different target tissue profile.

Option 3- Chronic insulin resistance

Chronic insulin resistance is a metabolic side effect that can develop secondary to cortisol excess. However, it is not the primary mechanism driving this patient's presentation. Cortisol does promote insulin resistance - it antagonizes insulin signaling in peripheral tissues, raises blood glucose, and can contribute to central adiposity over time. So insulin resistance is not entirely unrelated to this patient's condition.

This option requires careful reasoning because it contains a kernel of truth. However, the question asks for the mechanism that BEST explains the full clinical presentation - and insulin resistance alone does not explain proximal muscle weakness or purple striae. More importantly, insulin resistance in this patient is a downstream consequence of cortisol excess, not the primary driver. Selecting the secondary effect when the primary mechanism is available as an option is a reasoning error this question is specifically designed to test.

Option 4- Sustained cortisol elevation

Sustained cortisol elevation, produced by long-term prednisone use, activates glucocorticoid receptors in adipose tissue, skeletal muscle, and connective tissue, causing central fat redistribution, proximal myopathy from inhibited protein synthesis, and skin fragility from suppressed collagen production.

Prednisone is a synthetic glucocorticoid that mimics the effects of cortisol in the body. When glucocorticoid receptors are chronically activated across multiple tissue types, the downstream effects are widespread and predictable. In adipose tissue, cortisol promotes central fat redistribution – producing central adiposity. In skeletal muscle, cortisol's catabolic activity inhibits protein synthesis, leading to proximal myopathy and the weakness this patient exhibits. In connective tissue, cortisol suppresses collagen production, weakening the structural integrity of the skin and producing the purple striae from dermal tearing under the redistributed adipose tissue. Cortisol's mineralocorticoid-like activity also promotes sodium and water retention, contributing to hypertension. Every single finding in this patient's presentation is mechanistically explained by sustained cortisol elevation - making it the clear and complete answer.

When we trace each clinical finding - central adiposity, hypertension, proximal muscle weakness, and purple striae - back through the four proposed mechanisms, only sustained cortisol elevation accounts for all of them through a single unified physiologic pathway. The other three options each explain at most one finding, and none of them address the full clinical picture.

The correct answer is Option 4.

Let's explore the all student data:

63% of students selected Option 4 - Sustained cortisol elevation - the correct response
27% of students selected Option 1 - Excess aldosterone secretion
6% of students selected Option 3 - Chronic insulin resistance
4% of students selected Option 2 - Excess growth hormone secretion

System Classification
This question is an Other Systems question which represents approximately 18% of all exam items.

Content Outline Classification
This question is a Foundations for Evaluation, Differential Diagnosis, and Prognosis question which represents approximately 10% of all exam items.

Level Classification
This question is a Level 2 question since the question requires students to integrate numerous pieces of information or to apply knowledge in a given clinical scenario. Remediation of Level 2 questions occurs by increasing flexibility with academic content and by carefully analyzing decision making processes when answering applied examination questions.

Academic Focus Area

Looking to review related academic content? Check out pages 141, 539, and 657 in PTEXAM: The Complete Study Guide.